Table 1.
Clinical Information for Patients Treated With High-Dose UV-A1 Irradiation (130 J/cm2) 3 Times per Week for 14 Weeksa
| Lesional Induration (Scale, 0–9) |
Lesional Pigmentation (L* Value/Color) |
||||||
|---|---|---|---|---|---|---|---|
| Patient No./ Sex/Age, y |
Diagnosis | Disease Duration, y |
Treatment Location |
Before Therapy |
After Therapy |
Before Therapy |
After Therapy |
| 1/M/43 | Systemic scleroderma | 15 | Left leg | 7 | 3 | 59.4/medium | 49.1/dark |
| 2/F/15 | Scleroderma | 0.75 | Left leg | 8 | 5 | 58.1/medium | 40.3/dark |
| 3/F/74 | Acral scleroderma | 1 | Right middle finger | 7 | 4 | 62.5/medium | 46.1/dark |
| 4/F/42 | Systemic scleroderma | 18 | Left hand | 5 | 4 | 58.2/medium | 49.3/dark |
| 5/M/69 | Acral scleroderma | 28 | Right hand | 8 | 6 | 58.6/medium | 49.3/dark |
| 6/F/66 | Acral scleroderma | 4 | Right hand | 8 | 8 | 52.9/dark | 46.7/dark |
| 7/F/51 | Systemic scleroderma | 5 | Left forearm | 8 | 8 | 63.6/medium | 56.7/medium |
| 8/F/38 | Systemic scleroderma | 5 | Right arm | 6 | 6 | 60.1/medium | 47.4/dark |
| 9/M/48 | Sclerodermoid GVHD | 1 | Left forearm | 6 | 5 | 60.8/medium | 41.7/dark |
| 10/M/65 | Sclerodermoid GVHD | 3 | Left forearm | 6 | 4 | 53.7/dark | 50.5/dark |
| 11/F/45 | Sclerodermoid GVHD | 3 | Left axilla | 6 | 4 | 45.1/dark | 35.6/dark |
| 12/F/65 | Sclerodermoid GVHD | 1 | Left abdomen | 6 | 1 | 50.2/dark | 45.2/dark |
Abbreviation: GVHD, graft-vs-host disease.
a
The mean patient age was 51.8 years, the mean disease duration was 7.1 years, the mean lesional induration before therapy was 6.8 (after therapy, 4.8), and the mean lesional pigmentation (L* value) before therapy was 56.9 (after therapy, 46.5).